Redhill Biopharma Ltd (RDHL)
0.48
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.48
0.00 (0.00%)
After-Hours: 18:35
Redhill Biopharma Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 42.37% |
March 31, 2023 | |
December 31, 2022 | -29.14% |
September 30, 2022 | -203.4% |
June 30, 2022 | -63.83% |
March 31, 2022 | -156.7% |
December 31, 2021 | -110.4% |
September 30, 2021 | -98.97% |
June 30, 2021 | -135.4% |
March 31, 2021 | -111.1% |
December 31, 2020 | -113.4% |
September 30, 2020 | -88.99% |
June 30, 2020 | -76.78% |
March 31, 2020 | -1.62K% |
December 31, 2019 | -735.3% |
September 30, 2019 | -702.0% |
June 30, 2019 | -697.9% |
March 31, 2019 | -568.2% |
December 31, 2018 | -565.4% |
September 30, 2018 | -457.1% |
June 30, 2018 | -473.1% |
March 31, 2018 | -406.3% |
December 31, 2017 | -520.4% |
September 30, 2017 | -1.02K% |
Date | Value |
---|---|
June 30, 2017 | -2.28K% |
March 31, 2017 | |
December 31, 2016 | -8.35K% |
September 30, 2016 | |
June 30, 2016 | -655.2K% |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | -329.2K% |
June 30, 2015 | -659.6K% |
March 31, 2015 | -464.2K% |
December 31, 2014 | -532.8K% |
September 30, 2014 | -105.9K% |
June 30, 2014 | -113.1K% |
March 31, 2014 | 48.21% |
December 31, 2013 | -344.0K% |
September 30, 2013 | -89.97K% |
June 30, 2013 | -62.80K% |
March 31, 2013 | -49.42K% |
December 31, 2012 | -83.80K% |
September 30, 2012 | -65.57K% |
June 30, 2012 | -45.46K% |
March 31, 2012 | -68.35K% |
December 31, 2011 | -87.33K% |
September 30, 2011 | -24.81K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.62K%
Minimum
Mar 2020
42.37%
Maximum
Jun 2023
-306.6%
Average
-112.2%
Median
Profit Margin (Quarterly) Benchmarks
Compugen Ltd | 29.03% |
Pluri Inc | -7.45K% |
BioLine Rx Ltd | -289.2% |
Can Fite Biofarma Ltd | -1.07K% |
BiomX Inc | -- |